UROsphere presents scientific results at the International Continence Society (ICS) annual meeting (Barcelona, Spain, 26 – 30 August 2013).

The following scientific results will be presented :

DFL 14817, a new potent and selective TRPM8 antagonist for the treatment of urinary bladder disorders.
Palea S¹, Guilloteau V¹, Brandolini L², Guardia M¹, Rollet K¹, Guerard M¹, Bianchini G², Lluel P¹, Aramini A².
1. UROsphere, 2. Dompé S.p.A.
Podium Session 3 – Basic Science 1: Innovations
Wednesday 28th August 2013 – 11:05-12:05.
 

Modulation of PGE2-augmented micro-contractions by the non-selective ß-adrenoceptor agonist isoprenaline in isolated strips of rat urinary bladder.
Granato C¹, Korstanje C¹, Rouget C², Lluel P², Palea S², Gillespie J³.
1. Astellas Pharma Europe B.V., 2. UROsphere S.A.S., 3. Urophysiology Research Group, The Medical and Dental School, Newcastle University.
Podium Poster Session 9 – Basic Science 3: Cell and Tissue Interactions
Wednesday 28th August 2013 – 16:00-17:30.

Modulation of PGE2-augmented non-voiding activity by ß3-adrenoceptor agonist mirabegron in conscious rats.
Granato C¹, Korstanje C¹, Guilloteau V², Lluel P², Palea S², Gillespie J³
1. Astellas Pharma Europe B.V., 2. UROsphere S.A.S., 3. Urophysiology Research Group, The Medical and Dental School, Newcastle University
Podium Poster Session 9 – Basic Science 3: Cell and Tissue Interactions
Wednesday 28th August 2013 – 16:00 -17:30.
 

UROsphere’s top managers will be present during the meeting. If you wish to meet them, please contact us.